XP Chemistries reported a narrowed annual loss and continued progress toward regulatory approval for its sustainable capsaicin product, with commercial launch preparations underway and strong investor support through recent capital raises.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.